TAME-CLC: Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease (clinicaltrials.gov) - Jul 18, 2026 - P=N/A | N=27000 | Active, not recruiting | Sponsor: Seoul National University
New trial • Chronic Obstructive Pulmonary Disease • Immunology • Lung Cancer • Oncology • Pulmonary Disease • Respiratory Diseases • Solid Tumor
|